224 related articles for article (PubMed ID: 1649637)
1. The activation of adenylate cyclase by pituitary adenylate cyclase activating polypeptide (PACAP) via helodermin-preferring VIP receptors in human SUP-T1 lymphoblastic membranes.
Gourlet P; De Neef P; Woussen-Colle MC; Vandermeers A; Vandermeers-Piret MC; Robberecht P; Christophe J
Biochim Biophys Acta; 1991 Jul; 1066(2):245-51. PubMed ID: 1649637
[TBL] [Abstract][Full Text] [Related]
2. Characterization of binding sites for VIP-related peptides and activation of adenylate cyclase in developing pancreas.
Le Meuth V; Farjaudon N; Bawab W; Chastre E; Rosselin G; Guilloteau P; Gespach C
Am J Physiol; 1991 Feb; 260(2 Pt 1):G265-74. PubMed ID: 1847591
[TBL] [Abstract][Full Text] [Related]
3. Characterization of vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptors in human benign hyperplastic prostate.
Solano RM; Carmena MJ; Carrero I; Cavallaro S; Roman F; Hueso C; Travali S; Lopez-Fraile N; Guijarro LG; Prieto JC
Endocrinology; 1996 Jul; 137(7):2815-22. PubMed ID: 8770902
[TBL] [Abstract][Full Text] [Related]
4. PACAP and VIP receptors in rat liver membranes.
Robberecht P; Gourlet P; Cauvin A; Buscail L; De Neef P; Arimura A; Christophe J
Am J Physiol; 1991 Jan; 260(1 Pt 1):G97-102. PubMed ID: 1846275
[TBL] [Abstract][Full Text] [Related]
5. Presence of highly selective receptors for PACAP (pituitary adenylate cyclase activating peptide) in membranes from the rat pancreatic acinar cell line AR 4-2J.
Buscail L; Gourlet P; Cauvin A; De Neef P; Gossen D; Arimura A; Miyata A; Coy DH; Robberecht P; Christophe J
FEBS Lett; 1990 Mar; 262(1):77-81. PubMed ID: 2156735
[TBL] [Abstract][Full Text] [Related]
6. Structural requirements for the binding of the pituitary adenylate-cyclase-activating peptide to receptors and adenylate-cyclase activation in pancreatic and neuronal membranes.
Gourlet P; Woussen-Colle MC; Robberecht P; de Neef P; Cauvin A; Vandermeers-Piret MC; Vandermeers A; Christophe J
Eur J Biochem; 1991 Jan; 195(2):535-41. PubMed ID: 1997328
[TBL] [Abstract][Full Text] [Related]
7. Characterization of a common VIP-PACAP receptor in human small intestinal epithelium.
Salomon R; Couvineau A; Rouyer-Fessard C; Voisin T; Lavallée D; Blais A; Darmoul D; Laburthe M
Am J Physiol; 1993 Feb; 264(2 Pt 1):E294-300. PubMed ID: 8383439
[TBL] [Abstract][Full Text] [Related]
8. A new type of functional VIP receptor has an affinity for helodermin in human SUP-T1 lymphoblasts.
Robberecht P; Waelbroeck M; De Neef P; Tastenoy M; Gourlet P; Cogniaux J; Christophe J
FEBS Lett; 1988 Feb; 228(2):351-5. PubMed ID: 2830146
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological characterization of the novel helodermin/VIP receptor present in human SUP-T1 lymphoma cell membranes.
Robberecht P; De Neef P; Gourlet P; Cauvin A; Coy DH; Christophe J
Regul Pept; 1989; 26(2):117-26. PubMed ID: 2552509
[TBL] [Abstract][Full Text] [Related]
10. Molecular cloning and functional characterization of a human VIP receptor from SUP-T1 lymphoblasts.
Svoboda M; Tastenoy M; Van Rampelbergh J; Goossens JF; De Neef P; Waelbroeck M; Robberecht P
Biochem Biophys Res Commun; 1994 Dec; 205(3):1617-24. PubMed ID: 7811244
[TBL] [Abstract][Full Text] [Related]
11. Analogues of VIP, helodermin, and PACAP discriminate between rat and human VIP1 and VIP2 receptors.
Gourlet P; Vandermeers A; Van Rampelbergh J; De Neef P; Cnudde J; Waelbroeck M; Robberecht P
Ann N Y Acad Sci; 1998 Dec; 865():247-52. PubMed ID: 9928018
[TBL] [Abstract][Full Text] [Related]
12. Expression, pharmacological, and functional evidence for PACAP/VIP receptors in human lung.
Busto R; Carrero I; Guijarro LG; Solano RM; Zapatero J; Noguerales F; Prieto JC
Am J Physiol; 1999 Jul; 277(1):L42-8. PubMed ID: 10409229
[TBL] [Abstract][Full Text] [Related]
13. Properties of vasoactive-intestinal-peptide receptors and beta-adrenoceptors in the murine radiation leukemia-virus-induced lymphoma cell line BL/VL3.
Abello J; Damien C; De Neef P; Tastenoy M; Hooghe R; Robberecht P; Christophe J
Eur J Biochem; 1989 Aug; 183(2):263-7. PubMed ID: 2547606
[TBL] [Abstract][Full Text] [Related]
14. Receptors for pituitary adenylate cyclase-activating peptide in human liver.
Guijarro LG; Rodriguez-Henche N; García-López E; Noguerales F; Dapena MA; Juarranz MG; Prieto JC
J Clin Endocrinol Metab; 1995 Aug; 80(8):2451-7. PubMed ID: 7629241
[TBL] [Abstract][Full Text] [Related]
15. Interaction of lipophilic VIP derivatives with recombinant VIP1/PACAP and VIP2/PACAP receptors.
Gourlet P; Rathé J; De Neef P; Cnudde J; Vandermeers-Piret MC; Waelbroeck M; Robberecht P
Eur J Pharmacol; 1998 Jul; 354(1):105-11. PubMed ID: 9726637
[TBL] [Abstract][Full Text] [Related]
16. Addition of the (28-38) peptide sequence of PACAP to the VIP sequence modifies peptide selectivity and efficacy.
Gourlet P; Vandermeers A; Vandermeers-Piret MC; De Neef P; Robberecht P
Int J Pept Protein Res; 1996 Oct; 48(4):391-6. PubMed ID: 8919060
[TBL] [Abstract][Full Text] [Related]
17. Structural requirements for the occupancy of pituitary adenylate-cyclase-activating-peptide (PACAP) receptors and adenylate cyclase activation in human neuroblastoma NB-OK-1 cell membranes. Discovery of PACAP(6-38) as a potent antagonist.
Robberecht P; Gourlet P; De Neef P; Woussen-Colle MC; Vandermeers-Piret MC; Vandermeers A; Christophe J
Eur J Biochem; 1992 Jul; 207(1):239-46. PubMed ID: 1321043
[TBL] [Abstract][Full Text] [Related]
18. Receptors for VIP and PACAP in guinea pig cerebral cortex: effects on cyclic AMP synthesis and characterization by 125I-VIP binding.
Zawilska JB; Dejda A; Niewiadomski P; Gozes I; Nowak JZ
J Mol Neurosci; 2005; 25(3):215-24. PubMed ID: 15800375
[TBL] [Abstract][Full Text] [Related]
19. Antagonistic properties are shifted back to agonistic properties by further N-terminal shortening of pituitary adenylate-cyclase-activating peptides in human neuroblastoma NB-OK-1 cell membranes.
Vandermeers A; Vandenborre S; Hou X; de Neef P; Robberecht P; Vandermeers-Piret MC; Christophe J
Eur J Biochem; 1992 Sep; 208(3):815-9. PubMed ID: 1327769
[TBL] [Abstract][Full Text] [Related]
20. Characterization of a guanosine-nucleotide-binding-protein-coupled receptor for pituitary adenylate-cyclase-activating polypeptide on plasma membranes from rat brain.
Schäfer H; Schwarzhoff R; Creutzfeldt W; Schmidt WE
Eur J Biochem; 1991 Dec; 202(3):951-8. PubMed ID: 1662620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
